← Leaderboards
Emily Mae Rencsok
Harvard Medical School
$176,696
Attributed
$176,696
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54K · FY2022–25$100K$75K$50K$25K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$176,696 · 1
By mechanism
F30$176,696 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Ulrich H Von Andrian$44,950,919
- Gerhard Wagner$49,510,293
- Suzanne L. Walker$40,048,648
- Norbert Perrimon$95,273,017
- Margaret S Livingstone$26,690,669
Others in their field
Other Rising Stars on “Guidelines”
- Mari Ostendorf · University Of Washington$51,931,230
- Joon Sup Lee · Emory University$10,751,414
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Kurt Langenbach · Precision Bioservices, Inc.$8,884,583
- Robert C Alexander · Banner Health$8,197,111
- Deborah J Goff · Dana-Farber Cancer Inst$6,540,771
Research focus
GuidelinesAdvanced Prostate CancerEthnic OriginFunctional StatusAreaAustraliaBlack MenBlack PatientFailureCancer CareCancer ControlCancer PatientCareerCaringCommunicationConfidence IntervalsDiagnosisDisease ProgressionBlack RaceEuropean Organization For Research And Treatment Of CancerEnrollmentEnsureEquationHealth Personnel
Grant awards (4)
Racial disparities in advanced prostate cancer care: An analysis of treatment patterns and patient experience$31,173
F30 · FY2025 · CA · contact PI
Racial disparities in advanced prostate cancer care: An analysis of treatment patterns and patient experience$53,974
F30 · FY2024 · CA · contact PI
Racial disparities in advanced prostate cancer care: An analysis of treatment patterns and patient experience$52,694
F30 · FY2023 · CA · contact PI
Racial disparities in advanced prostate cancer care: An analysis of treatment patterns and patient experience$38,855
F30 · FY2022 · CA · contact PI